This is the authors' abstract. We don't add key points for this paper.
To develop a deep learning model for simultaneous segmentation of glioma lesions and classification of IDH mutation and 1p/19q codeletion status using multimodal MRI. We employed a CNN model with Encoder-Decoder architecture for segmentation, followed by fully connected layers for classification. The model was trained and validated using the BraTS 2020 dataset (132 examinations with known molecular status, split 80/20). Four MRI sequences iamges (T1, T1ce, T2, FLAIR) were used for analysis. Segmentation performance was evaluated using mean Dice Score (mDS) and mean Intersection over Union (mIoU). Classification was assessed using accuracy, sensitivity, and specificity. The model achieved the best segmentation performance with all four modalities (mDS validation = 0.73, mIoU validation = 0.62). Among single modalities, FLAIR performed best (mDS validation = 0.56, mIoU validation = 0.44). For classification, the combined four modalities achieved an overall accuracy of 0.98. However, classification precision for IDH and 1p19q was potentially limited by class imbalance. Our CNN-based Encoder-Decoder model demonstrates the benefit of multimodal MRI for accurate glioma segmentation and shows promising results for molecular subtype classification. Future work will focus on addressing class imbalance and exploring feature integration to enhance classification performance. • CNN-based model developed for glioma analysis. • Multimodal MRI significantly enhanced segmentation accuracy. • FLAIR contrast yielded best single-modality segmentation. • Combined modalities showed a solid performance in classification. • Class imbalance identified as a limitation for classification.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bjørkeli et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: